IDiyas

For the Inventor, By the Inventor

Farum, Denmark

Birgitte Langer Eriksen

USPTO Granted Patents = 22 

 

Average Co-Inventor Count = 5.2

ph-index = 5

Forward Citations = 41(Granted Patents)


Location History:

  • Ballerup, DK (2008 - 2011)
  • Farum, DK (2004 - 2020)

Company Filing History:

goldMedal16 out of 206 
 
Neurosearch A/s
 patents
silverMedal4 out of 4 
 
Ataxion, Inc.
 patents
bronzeMedal1 out of 17 
 
Cadent Therapeutics, Inc.
 patents
4. 1 out of 832,680 
Other
 patents

Years Active: 2004-2020

Loading Chart...
Loading Chart...
22 patents (USPTO):Explore Patents
1. 10774064 - Potassium channel modulators (2020-09-15),
2. 9340544 - Purinyl derivatives and their use as potassium channel modulators (2016-05-17),
3. 8765770 - [object Object] (2014-07-01),
4. 8685987 - Substituted [1,2,4]triazolo[1,5-a]pyrimidines and their use as potassium channel modulators (2014-04-01),
5. 8618099 - Pyrazolyl-pyrimidine derivatives and their use as potassium channel modulators (2013-12-31),
6. 8415358 - Pyrazine derivatives and their use as potassium channel modulators (2013-04-09),
7. 8362024 - Purinyl derivatives and their use as potassium channel modulators (2013-01-29),
8. 8268838 - Substituted purinyl-pyrazole derivatives and their use as potassium channel modulators (2012-09-18),
9. 8252806 - Potassium channel modulating agents and their medical use (2012-08-28),
10. 8222262 - Indazolyl derivatives useful as potassium channel modulating agents (2012-07-17),
11. 8110586 - 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors (2012-02-07),
12. 8093388 - 3-aza spiro[5,5]undec-8-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors (2012-01-10),
13. 8049012 - 3-aza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors (2011-11-01),
14. 8048877 - Guanidine derivatives and their medical use (2011-11-01),
15. 8039632 - 2-aminio-pyridine derivatives and their use as potassium channel modulators (2011-10-18),

Title: Birgitte Langer Eriksen: Pioneering Innovations in Potassium Channel Modulation

Introduction:

Birgitte Langer Eriksen, an esteemed inventor hailing from Farum, DK, has left an indelible mark on the world of pharmaceuticals through his groundbreaking work in potassium channel modulation. With a total of 22 patents to his name, Eriksen's relentless pursuit of excellence continues to inspire the next generation of inventors and shape the future of technology.

Latest Patents:

Among his latest patents are innovations in potassium channel modulation, including novel compounds and pharmaceutical compositions for treating a variety of diseases, disorders, or conditions associated with potassium channels. Eriksen's work on purinyl derivatives as potassium channel modulators showcases his commitment to advancing therapeutic interventions for a range of medical challenges.

Career Highlights:

Eriksen's career has been defined by his tenure at esteemed companies such as Neurosearch A/S and Ataxion, Inc. His expertise and dedication have led to significant advancements in the field of pharmaceuticals, particularly in the realm of potassium channel modulation. Eriksen's innovative solutions have garnered him recognition as a true pioneer in the industry.

Collaborations:

Throughout his career, Eriksen has worked alongside accomplished professionals in the field, including colleagues such as Dan Peters and Charlotte Hougaard. These collaborations have not only enriched Eriksen's own work but have also contributed to a collaborative spirit within the industry, fostering a culture of innovation and shared success.

Conclusion:

In conclusion, Birgitte Langer Eriksen stands as a shining example of innovation and dedication in the world of pharmaceutical research. His pioneering work in potassium channel modulation has led to significant advancements in the treatment of various diseases and has set a high standard for the next generation of inventors to aspire to. Eriksen's contributions will undoubtedly continue to shape the future of technology and pave the way for new and improved therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…